Bridgefront Capital’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-17,141
Closed -$243K 582
2021
Q2
$243K Buy
+17,141
New +$243K 0.09% 429